BHC - Bausch Health Companies - Stock & Dividends

Exchange: USA Stocks • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA0717341071

Gastro, Dermatology, Neurology, Pharmaceuticals, Aesthetic Devices, Ophthalmic Products

Bausch Health Companies Inc. is a leading global pharmaceutical and medical device company that operates in the United States and internationally. The company develops, manufactures, and markets a diverse range of products that cater to various therapeutic areas, including gastroenterology, hepatology, neurology, dermatology, and eye health.

With a strong presence in the pharmaceutical industry, Bausch Health Companies Inc. operates through five key segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment focuses on providing gastroenterology products in the United States, while the International segment sells a range of products, including aesthetic medical devices, branded and generic pharmaceuticals, and over-the-counter (OTC) products in international markets.

The Solta Medical segment specializes in the sale of aesthetic medical devices, which are designed to improve the appearance and health of the skin. The Diversified segment, on the other hand, offers a range of pharmaceutical products in areas such as neurology, ortho dermatology, and dentistry in the United States. Additionally, the segment provides generic products that cater to various therapeutic classes.

The Bausch + Lomb segment is a leading global eye health company that offers a range of products, including vision care, surgical, and ophthalmic pharmaceuticals. The company's commitment to innovation and quality has enabled it to establish a strong presence in the eye health market.

Formerly known as Valeant Pharmaceuticals International, Inc., Bausch Health Companies Inc. rebranded in July 2018 to reflect its commitment to innovation, quality, and customer satisfaction. Headquartered in Laval, Canada, the company continues to drive growth and innovation in the pharmaceutical and medical device industries.

For more information about Bausch Health Companies Inc., please visit their website at https://www.bauschhealth.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BHC - Bausch Health Companies  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for BHC - Bausch Health Companies  - Stock & Dividends

BHC Stock Overview

Market Cap in USD 2,713m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1994-03-29

BHC Stock Ratings

Growth 5y -50.6
Fundamental -16.4
Dividend 0.00
Rel. Performance vs Sector -1.44
Analysts 3.11/5
Fair Price Momentum 6.50 USD
Fair Price DCF 59.98 USD

BHC Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 15.0%

BHC Growth Ratios

Growth 12m -20.75%
Growth Correlation 12m -16%
Growth Correlation 3m -9%
CAGR 5y -20.00%
CAGR/Mean DD 5y -0.42
Sharpe Ratio 12m -0.67
Alpha vs SP500 12m -48.22
Beta vs SP500 5y weekly 1.25
ValueRay RSI 75.18
Volatility GJR Garch 1y 49.02%
Price / SMA 50 11.93%
Price / SMA 200 -2.81%
Current Volume 3564.2k
Average Volume 20d 3065.3k

External Links for BHC Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BHC stocks?
As of July 20, 2024, the stock is trading at USD 7.60 with a total of 3,564,182 shares traded.
Over the past week, the price has changed by +2.43%, over one month by +12.93%, over three months by -12.54% and over the past year by -20.59%.
What are the forecast for BHC stock price target?
According to ValueRays Forecast Model, BHC Bausch Health Companies will be worth about 7 in July 2025. The stock is currently trading at 7.60. This means that the stock has a potential downside of -7.63%.
Issuer Forecast Upside
Wallstreet Target Price 9.6 25.9
Analysts Target Price 9.7 27.2
ValueRay Target Price 7 -7.63